Its most serious acute complication, namely pulmonary embolus ... removal include catheter-directed thrombolysis, mechanical thrombectomy and various combinations of both (pharmacomechanical ...

Mechanical thrombectomy is effective and safe for treating pulmonary embolism (PE). Although the Tendvia mechanical thrombectomy system has been validated in pigs, further evidence supporting its ...

Endovascular Engineering (E2) announced today that it raised $42 million in an oversubscribed Series B financing round.

Akura Medical has enrolled the first subject in the multi-centre QUADRA-PE trial, which is assessing its flagship Katana thrombectomy system in treating acute pulmonary embolism (PE) patients.

According to GlobalData, the worldwide thrombectomy device market was worth $2.96 billion in 2024 and is set to register a ...

LOS GATOS, Calif., Feb. 4, 2025 /PRNewswire/ -- Akura Medical, a Shifamed portfolio company focused on reshaping the landscape of venous thromboembolism (VTE) care, announced today the first ...

Endovascular Engineering, Inc. (E2) announced it has secured $42 million in oversubscribed Series B financing to advance its n ...

Thrombolysis is an accepted practice for treating massive pulmonary embolism and hemodynamic instability. These authors evaluated whether thrombolysis is also effective for patients with ...

Late-breaking data from the ENGULF trial showed that a novel dual-action thrombectomy device was effective and safe in treating acute pulmonary embolism (PE). The safety and effectiveness results ...

The Portage, Michigan–based orthopedic and surgical device giant announced last month that it struck a deal to acquire Inari ...